VERTICAL Phase II trial results for NHL released
The Takeda Oncology Company today reported data from a clinical trial evaluating a VELCADE based combination for patients with relapsed/refractory non-Hodgkin’s lymphoma (NHL).

Read more on News-Medical-Net